Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 448, 33-34 (5 July 2007) | doi:10.1038/448033a; Published online 4 July 2007
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
PhD Programs
- Georg-August-Universitat Gottingen
- Göttingen, Germany
Associate Professor or Full Professor
- South Dakota State University
- Brookings, SD
Molecular medicine: Entry granted
Edouard M. Cantin1 & John J. Rossi1
Abstract
The inability to efficiently deliver small interfering RNAs to target organs hinders their therapeutic application. So a demonstration of siRNA delivery to a notoriously difficult organ — the brain — is very exciting indeed.
The process of RNA interference (RNAi) uses small RNA triggers to decrease gene expression in a sequence-specific manner. In most applications, a small interfering RNA (siRNA) sequence — 21–23 nucleotides long — silences a target messenger RNA with a complementary sequence by either directing site-specific cleavage or inhibiting its translation into a protein1, 2.
- Edouard M. Cantin and John J. Rossi are at the Beckman Research Institute of the City of Hope, and City of Hope Graduate School of Biological Sciences, Duarte, California 91010, USA.
Email: jrossi@bricoh.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Transvascular delivery of small interfering RNA to the central nervous systemNature Article (05 Jul 2007)
